Shariah compliance overview
Not HalalProtagonist Therapeutics, Inc. (PTGX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders.
Protagonist Therapeutics, Inc. (PTGX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity.
- Business Activity
- 38.49%Limit 5%Fail
- Interest-bearing debt
- 0.06%Limit 30%Pass
- Interest-bearing securities and assets
- 15.94%Limit 30%Pass
- Dividend purification
- 38.49%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Protagonist Therapeutics, Inc. (PTGX). Current Akinda screening label: Not Halal.
